IdentificationofNovelFalcipain-2InhibitorsasPotentialAntimalarialAgentsthroughStructure-Based Virtual Screening

[1]  P. Rosenthal,et al.  Plasmodium falciparum: inhibitors of lysosomal cysteine proteinases inhibit a trophozoite proteinase and block parasite development. , 1989, Molecular and biochemical parasitology.

[2]  L. Goh,et al.  Homology modeling and mutagenesis analyses of Plasmodium falciparum falcipain 2A: implications for rational drug design. , 2004, Biochemical and biophysical research communications.

[3]  Narelle Towie,et al.  Malaria breakthrough raises spectre of drug resistance , 2006, Nature.

[4]  Philip J. Rosenthal,et al.  Antimalarial Activities of Novel Synthetic Cysteine Protease Inhibitors , 2003, Antimicrobial Agents and Chemotherapy.

[5]  David Rogers,et al.  Cheminformatics analysis and learning in a data pipelining environment , 2006, Molecular Diversity.

[6]  Sanjay Batra,et al.  Structure-based approach to falcipain-2 inhibitors: synthesis and biological evaluation of 1,6,7-trisubstituted dihydroisoquinolines and isoquinolines. , 2003, Bioorganic & medicinal chemistry.

[7]  Jochen Wiesner,et al.  New antimalarial drugs. , 2003, Angewandte Chemie.

[8]  Honglin Li,et al.  GAsDock: a new approach for rapid flexible docking based on an improved multi-population genetic algorithm. , 2004, Bioorganic & medicinal chemistry letters.

[9]  Jiri Gut,et al.  Synthesis and evaluation of new antimalarial phenylurenyl chalcone derivatives. , 2005, Journal of medicinal chemistry.

[10]  Kelly Chibale,et al.  Synthesis and evaluation of isatins and thiosemicarbazone derivatives against cruzain, falcipain-2 and rhodesain. , 2003, Bioorganic & medicinal chemistry letters.

[11]  Robert D Clark,et al.  Neighborhood behavior: a useful concept for validation of "molecular diversity" descriptors. , 1996, Journal of medicinal chemistry.

[12]  Kelly Chibale,et al.  Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi. , 2004, Journal of medicinal chemistry.

[13]  William R. Roush,et al.  Structure-Activity Relationships for Inhibition of Cysteine Protease Activity and Development of Plasmodium falciparum by Peptidyl Vinyl Sulfones , 2003, Antimicrobial Agents and Chemotherapy.

[14]  Xu Shen,et al.  Structural and Functional Characterization of Falcipain-2, a Hemoglobinase from the Malarial Parasite Plasmodium falciparum* , 2006, Journal of Biological Chemistry.

[15]  P. Rosenthal,et al.  Recombinant falcipain-2 cleaves erythrocyte membrane ankyrin and protein 4.1. , 2001, Molecular and biochemical parasitology.

[16]  Nikola Biller-Andorno,et al.  Infectious diseases – A global challenge , 2006, International Journal of Medical Microbiology.

[17]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[18]  J T Palmer,et al.  Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase. , 1991, The Journal of clinical investigation.

[19]  Hege S. Beard,et al.  Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.

[20]  Prashant V Desai,et al.  Probing the structure of falcipain‐3, a cysteine protease from Plasmodium falciparum: Comparative protein modeling and docking studies , 2003, Protein science : a publication of the Protein Society.

[21]  G Padmanaban,et al.  Drug targets in malaria parasites. , 2003, Advances in biochemical engineering/biotechnology.

[22]  Kiaran Kirk,et al.  The malaria parasite's chloroquine resistance transporter is a member of the drug/metabolite transporter superfamily. , 2004, Molecular biology and evolution.

[23]  Jiri Gut,et al.  Identification of novel parasitic cysteine protease inhibitors using virtual screening. 1. The ChemBridge database. , 2004, Journal of medicinal chemistry.

[24]  Ashutosh Kumar Singh,et al.  Characterization of Native and Recombinant Falcipain-2, a Principal Trophozoite Cysteine Protease and Essential Hemoglobinase ofPlasmodium falciparum * , 2000, The Journal of Biological Chemistry.

[25]  Prashant Desai,et al.  Homology Modeling of Falcipain-2: Validation, De Novo Ligand Design and Synthesis of Novel Inhibitors , 2002, Journal of biomolecular structure & dynamics.

[26]  Gang Chen,et al.  A New Rapid and Effective Chemistry Space Filter in Recognizing a Druglike Database , 2005, J. Chem. Inf. Model..

[27]  David A. Fidock,et al.  Antimalarial drug discovery: efficacy models for compound screening , 2004, Nature Reviews Drug Discovery.

[28]  S H Kaufmann,et al.  Successful virtual screening of a chemical database for farnesyltransferase inhibitor leads. , 2000, Journal of medicinal chemistry.

[29]  Jiri Gut,et al.  Identification of novel parasitic cysteine protease inhibitors by use of virtual screening. 2. The available chemical directory. , 2006, Journal of medicinal chemistry.

[30]  W. Graham Richards,et al.  Ultrafast shape recognition to search compound databases for similar molecular shapes , 2007, J. Comput. Chem..

[31]  D. Rognan,et al.  Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. , 2000, Journal of medicinal chemistry.

[32]  Nicholas J White,et al.  Antimalarial drug resistance. , 2004, The Journal of clinical investigation.